Clinical trial
Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease
NCT01538212 is registered in ClinicalTrials.gov with Cerecin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease
- Lead sponsor
- Cerecin
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- October 31, 2012
- Enrollment
- 55 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease